Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)
Titel:
Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)
Auteur:
Murakami, H. Tamura, T. Takahashi, T. Nokihara, H. Naito, T. Nakamura, Y. Nishio, K. Seki, Y. Sarashina, A. Shahidi, M. Yamamoto, N.